Effects of moderate smoking on the central visual field

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 4, 2004, Pages 432-435

  Akarsu, Cengiz ^a,c   Yazici, Bülent ^b   Taner, Pelin ^a   Ergin, Ahmet ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Blue on yellow perimetry; Moderate cigarette smoking; Visual field; White on white perimetry

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERIMETRY; PRIORITY JOURNAL; PROBABILITY; RETINA FOVEA; SENSITIVITY AND SENSIBILITY; STATISTICAL ANALYSIS; TRAINING; VISUAL FIELD; VISUAL SYSTEM EXAMINATION; VISUAL THRESHOLD;

ADULT; FEMALE; HUMANS; MALE; PERIMETRY; RETINAL DISEASES; SENSORY THRESHOLDS; SMOKING; VISION DISORDERS; VISUAL FIELDS;

EID: 4444360982     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1395-3907.2004.00301.x     Document Type: Article

References (20)

1. Advanced Glaucoma Intervention Study Investigators (1994): The Advanced Glaucoma Intervention Study 2. Visual field test scoring and reliability. Ophthalmology 101: 1445-1455.
2. Age-Related Eye Disease Study Research Group (2000): Risk factors associated with age-related macular degeneration: a case-control study in the Age-related Eye Disease Study. Age-related Eye Disease Study Report No. 3. Ophthalmology 107: 2224-2232.
3. Chung SM, Gay CA & McCrary JA (1994): Non-arteritic ischaemic optic neuropathy: the impact of tobacco use. Ophthalmology 101: 781-783.
4. Congdon NG (2001): Prevention strategies for age-related cataract: present limitations and future possibilities. Br J Ophthalmol 85: 516-520.
5. Cryer PE, Haymond MW, Santiago JV & Shah SD (1976): Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated haemodynamic and metabolic events. N Engl J Med 295: 573-577.
6. Fielding JE (1985): Smoking: health effects and control. N Engl J Med 313: 491-498.
7. Heijl A & Bengtsson B (1996): The effect of perimetric experience in patients with glaucoma. Arch Ophthalmol 114: 19-22.
8. Hepsen IF & Evereklioglu C (2001): Defective visual field tests in chronic heavy smokers. Acta Ophthalmol Scand 79: 53-56.
9. Johnson CA, Adams AJ, Casson EJ & Brandt JD (1993): Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 111: 645-650.
10. Klein R, Klein BE, Moss SE & Meuer SM (2000): The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98: 133-141.
11. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ & Taylor HR (2001): Risk factors for age-related maculopathy. Arch Ophthalmol 119: 1455-1462.
12. Morrow JD, Frei B, Longmire AW et al. (1995): Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 332: 1198 1203.
13. Potts AM (1973): Tobacco amblyopia. Surv Ophthalmol 17: 313-339.
14. Raij L, DeMaster EG & Jaimes EA (2001): Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens 19: 891-897.
15. Rizzo JF III & Lessell S (1993): Tobacco amblyopia. Am J Ophthalmol 116: 84 87.
16. Shine B, Fells P, Edwards OM & Weetman AP (1990): Association between Graves' ophthalmopathy and smoking. Lancet 335: 1261-1263.
17. Solberg Y, Rosner M & Belkin M (1998): The association between cigarette smoking and ocular diseases. Surv Ophthalmol 42: 535-547.
18. Wild JM (2001): Short wavelength automated perimetry. Acta Ophthalmol Scand 79: 546-559.
19. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K & Epstein DL (1987): A case-control study of risk factors in open-angle glaucoma. Arch Ophthalmol 105: 1066-1071.
20. Wu SY & Leske MC (1997): Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol 115: 1572-1576.